Menu
Currency
GWAS Study

Uniting biobank resources reveals novel genetic pathways modulating susceptibility for atopic dermatitis.

Sliz E, Huilaja L, Pasanen A et al.

34454985 PubMed ID
GWAS Study Type
796661 Participants
100 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SE
Sliz E
HL
Huilaja L
PA
Pasanen A
LT
Laisk T
RE
Reimann E
MR
Mägi R
HK
Hannula-Jouppi K
PS
Peltonen S
ST
Salmi T
KL
Koulu L
TK
Tasanen K
KJ
Kettunen J
Chapter II

Abstract

Summary of the research findings

Atopic dermatitis (AD) is a common chronic inflammatory skin disease with high heritability. Previous genome-wide association studies have identified several loci predisposing to AD. These findings explain approximately 30% of the variance in AD susceptibility, suggesting that further work is required to fully understand the genetic underpinnings.

22,474 European ancestry cases, 774,187 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

796661
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Finland, U.K., Estonia
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.